Moderna Earnings: Raising Fair Value Estimate as Steadying Demand for Respiratory Vaccines Supports Strong Quarter
· morningstar.com · popularity 15/100 · 0 similar stories today · Public Health & Epidemiology (Health & Life Sciences)
Read the original at morningstar.com →
Summary
Moderna’s revenue growth also reflects revenue from international vaccine partnerships and the brightening US policy outlook. Key Morningstar Metrics …
Found in: Stocks. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 20.